Publication Name	World Journal of Gastroenterology
Manuscript ID	20507
Country	Belgium

Received	2015-06-08 10:46
Peer-Review Started	2015-06-11 09:10
To Make the First Decision	2015-07-14 12:01
Return for Revision	2015-07-27 19:47
Revised	2015-08-11 22:44
Second Decision	2015-10-16 13:12
Accepted by Journal Editor-in-Chief	2015-10-19 09:04
Accepted by Company Editor-in-Chief	2015-10-26 17:57
Articles in Press	2015-10-26 17:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-11 15:47
Publish the Manuscript Online	2015-12-31 13:27

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Current status and perspectives of immune-based therapies for hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Maridi Aerts, Daphné Benteyn, Hans Van Vlierberghe, Kris Thielemans and Hendrik Reynaert
Funding Agency and Grant Number	Funding Agency Grant Number Kankerplan Action 29, Ministry of health to Aerts M Flemish Fund for Research (FWO)
Corresponding Author	Hendrik Reynaert, MD, PhD, Professor, University hospital, UZ Brussel, Department of Gastroenterology and Hepatology, Laarbeeklaan 101, 1090 Brussels, Belgium. hendrik.reynaert@uzbrussel.be
Key Words	Hepatocellular carcinoma; Immunotherapy; Dendritic cells; Dendritic cell vaccination; Therapy
Core Tip	Hepatocellular carcinoma is a frequent cancer with a high mortality. For early stage cancer there are potentially curative treatments including local ablation, resection and liver transplantation. However, recurrence or development of a new tumor after treatment are not uncommon. Moreover, for more advanced stage disease, there is no optimal treatment available. Thus, there is an urgent need for novel and effective therapies for advanced stage hepatocellular carcinoma, and to prevent and to treat recurrence after local treatment of hepatocellular carcinoma.
Publish Date	2015-12-31 13:27
Citation	Aerts M, Benteyn D, Van Vlierberghe H, Thielemans K, Reynaert H. Current status and perspectives of immune-based therapies for hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 253-261
URL	http://www.wjgnet.com/1007-9327/full/v22/i1/253.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i1.253

Full Article (PDF)	WJG-22-253.pdf
Full Article (Word)	WJG-22-253.doc
Manuscript File	20507-Review.docx
Answering Reviewers	20507-Answering reviewers.pdf
Audio Core Tip	20507-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20507-Conflict-of-interest statement.pdf
Copyright License Agreement	20507-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	20507-Language certificate.pdf
Peer-review Report	20507-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	20507-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	20507-Scientific misconduct check.pdf
Scientific Editor Work List	20507-Scientific editor work list.pdf